Related Experiment Videos
Growth regulators in connective tissue. Systemic administration of an aortic extract inhibits tumor growth in mice
Abstract:
A low-molecular-weight fraction prepared from extracts of bovine aorta inhibits the growth of a transplantable mammary tumor and a fibrosarcoma in mice when injected systemically. It also inhibits the growth of the fibrosarcoma in cell culture. The effect on the fibrosarcoma is much more marked than on the mammary tumor. Since the extract is more effective against the fibrosarcoma and is known to inhibit the growth of endothelial cells, it appears that the enhanced effect on this tumor is due to its activity on the endothelial cells of the host and the tumor cells themselves. The material injected is enriched in an antiproteinase we have previously isolated, which has anticollagneolytic activity and is presumed to be the effector molecule.
Insights
A bovine aorta extract significantly inhibits tumor growth in mice, particularly fibrosarcomas. This extract, rich in an antiproteinase, shows potential as an anti-cancer agent by targeting endothelial and tumor cells.
Area of Science:
- Biochemistry
- Oncology
- Cell Biology
Background:
- Tumor growth is a complex process involving cell proliferation and vascularization.
- Identifying novel therapeutic agents that target tumor microenvironments is crucial for cancer treatment.
Purpose of the Study:
- To investigate the anti-tumorigenic effects of a low-molecular-weight fraction from bovine aorta extracts.
- To determine the specific cellular targets and mechanisms underlying the observed anti-tumor activity.
Main Methods:
- Preparation of a low-molecular-weight fraction from bovine aorta extracts.
- Systemic administration of the fraction to mice bearing transplantable mammary tumors and fibrosarcomas.
- In vitro assessment of the fraction's effect on fibrosarcoma cell growth.
- Analysis of the fraction's composition, identifying an antiproteinase with anticollagenolytic activity.
Main Results:
- The bovine aorta extract fraction demonstrated significant inhibition of both mammary tumor and fibrosarcoma growth in vivo.
- The fraction markedly inhibited fibrosarcoma growth in cell culture.
- The anti-tumor effect was more pronounced against fibrosarcoma compared to mammary tumors.
- The extract's efficacy is hypothesized to stem from its inhibitory action on endothelial cells and tumor cells.
Conclusions:
- A low-molecular-weight fraction from bovine aorta possesses potent anti-tumor properties against specific cancer types.
- The identified antiproteinase with anticollagenolytic activity is likely the key effector molecule responsible for the observed anti-tumor effects.
- This fraction holds promise as a potential therapeutic agent, particularly for fibrosarcomas, by targeting both tumor and vascular components.